These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37406589)

  • 21. Deeply integrating latent consistent representations in high-noise multi-omics data for cancer subtyping.
    Cai Y; Wang S
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38426322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting Drug Response Based on Multi-Omics Fusion and Graph Convolution.
    Peng W; Chen T; Dai W
    IEEE J Biomed Health Inform; 2022 Mar; 26(3):1384-1393. PubMed ID: 34347616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fair experimental comparison of neural network architectures for latent representations of multi-omics for drug response prediction.
    Hauptmann T; Kramer S
    BMC Bioinformatics; 2023 Feb; 24(1):45. PubMed ID: 36788531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DeepDSC: A Deep Learning Method to Predict Drug Sensitivity of Cancer Cell Lines.
    Li M; Wang Y; Zheng R; Shi X; Li Y; Wu FX; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):575-582. PubMed ID: 31150344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating multi-omics data through deep learning for accurate cancer prognosis prediction.
    Chai H; Zhou X; Zhang Z; Rao J; Zhao H; Yang Y
    Comput Biol Med; 2021 Jul; 134():104481. PubMed ID: 33989895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated multi-omics analysis of ovarian cancer using variational autoencoders.
    Hira MT; Razzaque MA; Angione C; Scrivens J; Sawan S; Sarker M
    Sci Rep; 2021 Mar; 11(1):6265. PubMed ID: 33737557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network-based drug sensitivity prediction.
    Ahmed KT; Park S; Jiang Q; Yeu Y; Hwang T; Zhang W
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):193. PubMed ID: 33371891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
    Malik V; Kalakoti Y; Sundar D
    BMC Genomics; 2021 Mar; 22(1):214. PubMed ID: 33761889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cancer risk groups through multi-omics integration using autoencoder and tensor analysis.
    Braytee A; He S; Tang S; Sun Y; Jiang X; Yu X; Khatri I; Chaturvedi K; Prasad M; Anaissi A
    Sci Rep; 2024 May; 14(1):11263. PubMed ID: 38760420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery.
    Lan W; Liao H; Chen Q; Zhu L; Pan Y; Chen YP
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38678587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtype-MGTP: a cancer subtype identification framework based on multi-omics translation.
    Xie M; Kuang Y; Song M; Bao E
    Bioinformatics; 2024 Jun; 40(6):. PubMed ID: 38857453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCGAplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data.
    Liao C; Wang X
    BMC Bioinformatics; 2023 Dec; 24(1):483. PubMed ID: 38105215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
    Huang S; Hu P; Lakowski TM
    BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of drug response in multilayer networks based on fusion of multiomics data.
    Yu L; Zhou D; Gao L; Zha Y
    Methods; 2021 Aug; 192():85-92. PubMed ID: 32798653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MOLI: multi-omics late integration with deep neural networks for drug response prediction.
    Sharifi-Noghabi H; Zolotareva O; Collins CC; Ester M
    Bioinformatics; 2019 Jul; 35(14):i501-i509. PubMed ID: 31510700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.
    Zhang T; Zhang L; Payne PRO; Li F
    Methods Mol Biol; 2021; 2194():223-238. PubMed ID: 32926369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DeepCDR: a hybrid graph convolutional network for predicting cancer drug response.
    Liu Q; Hu Z; Jiang R; Zhou M
    Bioinformatics; 2020 Dec; 36(Suppl_2):i911-i918. PubMed ID: 33381841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-step multi-omics modelling of drug sensitivity in cancer cell lines to identify driving mechanisms.
    Kusch N; Schuppert A
    PLoS One; 2020; 15(11):e0238961. PubMed ID: 33226984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
    Ali M; Khan SA; Wennerberg K; Aittokallio T
    Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.